Appreciate the sentiments and you clearly have an understanding of the background and work it has taken to get NEU to this point but without meaning any disrespect I completely disagree that “FDA approval is hardly an issue here” or for that matter that significant patience is required with respect to share price.
FDA approval is a massive issue here - the most important event this company has faced to date IMO. As has been discussed here recently highly likely but by no means a certainty. With FDA approval NEU is an income generating cash cow with 4 phase 2 trials cooking away and becomes a massive takeover target before or after those phase 2 results are known. Share price given FDA approval has to be north of $12 I believe and will likely rise through 2023. Without FDA approval NEU has significant funding issues again, 4 phase 2 trials that wouldn’t look anywhere near as promising with an unproven drug 5+ years from commercialisation and a share price of (I’m guessing) approximately $1.
All of which is going to unfold in the next 40 trading days if not before. Any chance you could explain how you could possibly think otherwise??
- Forums
- ASX - By Stock
- Share Price
Appreciate the sentiments and you clearly have an understanding...
-
-
- There are more pages in this discussion • 8,946 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 400 | 13.960 |
3 | 2997 | 13.950 |
1 | 1828 | 13.930 |
Price($) | Vol. | No. |
---|---|---|
14.070 | 3070 | 3 |
14.080 | 323 | 2 |
14.100 | 1828 | 1 |
14.130 | 1828 | 1 |
14.150 | 1828 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEU (ASX) Chart |